- Home
- FOXF vs VERA Comparison
FOXF vs VERA Comparison
Compare FOXF & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXF
- VERA
- Stock Information
- Founded
- FOXF 2007
- VERA 2016
- Country
- FOXF United States
- VERA United States
- Employees
- FOXF N/A
- VERA N/A
- Industry
- FOXF Motor Vehicles
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- FOXF Consumer Discretionary
- VERA Health Care
- Exchange
- FOXF Nasdaq
- VERA Nasdaq
- Market Cap
- FOXF 1.6B
- VERA 2.5B
- IPO Year
- FOXF N/A
- VERA 2021
- Fundamental
- Price
- FOXF $37.00
- VERA $42.01
- Analyst Decision
- FOXF Hold
- VERA Strong Buy
- Analyst Count
- FOXF 6
- VERA 9
- Target Price
- FOXF $46.17
- VERA $53.56
- AVG Volume (30 Days)
- FOXF 293.5K
- VERA 683.6K
- Earning Date
- FOXF 10-31-2024
- VERA 11-07-2024
- Dividend Yield
- FOXF N/A
- VERA N/A
- EPS Growth
- FOXF N/A
- VERA N/A
- EPS
- FOXF 0.98
- VERA N/A
- Revenue
- FOXF $1,345,575,000.00
- VERA N/A
- Revenue This Year
- FOXF N/A
- VERA N/A
- Revenue Next Year
- FOXF $10.04
- VERA N/A
- P/E Ratio
- FOXF $37.96
- VERA N/A
- Revenue Growth
- FOXF N/A
- VERA N/A
- 52 Week Low
- FOXF $34.56
- VERA $9.68
- 52 Week High
- FOXF $86.14
- VERA $50.78
- Technical
- Relative Strength Index (RSI)
- FOXF 40.65
- VERA 52.57
- Support Level
- FOXF $36.65
- VERA $39.22
- Resistance Level
- FOXF $38.36
- VERA $50.00
- Average True Range (ATR)
- FOXF 1.35
- VERA 2.41
- MACD
- FOXF -0.21
- VERA 0.24
- Stochastic Oscillator
- FOXF 20.19
- VERA 28.53
About FOXF Fox Factory Holding Corp.
Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.